Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study

被引：0
|
作者：
Hedner, J.
Loft, H.
Hajak, G.
Lundahl, J.
Hedegaard, K.
Knoth, Sorensen H.
Torstenson, R.
机构：
[1] Sahlgrens Univ Hosp, Gothenburg, Sweden
[2] Univ Regensburg, D-8400 Regensburg, Germany
来源：
SLEEP | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
741
引用
收藏
页码：A252 / A253
页数：2
相关论文
共 50 条
  • [1] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 4-week, double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    [J]. SLEEP, 2007, 30 : A249 - A249
  • [2] Efficacy and tolerability of gaboxadol in adults with primary insomnia: A 3-month, randomized, double-blind, placebo-controlled trial
    Anderson, D.
    Roth, T.
    Zheng, Y.
    Vandormael, K.
    Smith, A.
    Li, M.
    Digravio, D.
    [J]. SLEEP, 2007, 30 : A234 - A234
  • [3] Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
    Kohsaka, Masako
    Kanemura, Takashi
    Taniguchi, Mitsutaka
    Kuwahara, Hiroo
    Mikami, Akira
    Kamikawa, Kunihisa
    Uno, Hideki
    Ogawa, Atsushi
    Murasaki, Mitsukuni
    Sugita, Yoshiro
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (10) : 1389 - 1397
  • [4] The effects of tiagabine in elderly patients with primary insomnia: A double-blind, placebo-controlled study
    Wright, KP
    Roth, T
    [J]. SLEEP, 2005, 28 : A250 - A250
  • [5] Long-term safety of gaboxadol in the treatment of elderly patients with primary insomnia: A 12month, double-blind, placebo-controlled clinical trial
    Bodkin, J.
    Anderson, D.
    Zheng, Y.
    Golm, G.
    Gottwald, R.
    Kametz, K.
    [J]. SLEEP, 2007, 30 : A238 - A239
  • [6] A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with PDD or DLB
    Emre, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 338 - 338
  • [7] Double-blind, placebo-controlled outpatient clinical trial of ramelteon for the treatment of chronic insomnia in an elderly population
    Seiden, D
    Zee, P
    Weigand, S
    Sainati, S
    Bayuk, J
    Zhang, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A228 - A228
  • [8] EFFICACY OF PRAZOSIN IN THE MANAGEMENT OF CHRONIC CONGESTIVE HEART-FAILURE - A 6-MONTH RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MARKHAM, RV
    CORBETT, JR
    GILMORE, A
    PETTINGER, WA
    FIRTH, BG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (08): : 1346 - 1352
  • [9] Efficacy and tolerability of Indiplon-MR in elderly patients with chronic insomnia: Results of a double-blind, placebo-controlled, 2-week trial
    Lankford, J
    Lydiard, R
    Walsh, JK
    Seiden, D
    Jochelson, P
    [J]. SLEEP, 2005, 28 : A230 - A230
  • [10] Double-blind, placebo-controlled polysomnography and outpatient trial to evaluate the efficacy and safety of ramelteon in adult patients with chronic insomnia
    Zammit, G
    Roth, T
    Erman, W
    Sainati, S
    Weigand, S
    Zhang, Y
    [J]. SLEEP, 2005, 28 : A228 - A229
12345